Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

28.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Peripheral Nerve-Derived Pluripotent Cells Can Be Stimulated by In Vitro Bone Morphogenetic Protein-2.

Bioengineering (Basel, Switzerland)·2021
Same author

Cervical fusion for treatment of degenerative conditions: development of appropriate use criteria.

The spine journal : official journal of the North American Spine Society·2021
Same author

Effect of BMP-2 Adherent to Resorbable Sutures on Cartilage Repair: A Rat Model of Xyphoid Process.

Materials (Basel, Switzerland)·2020
Same author

Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder: A systematic scoping review.

The journal of spinal cord medicine·2018
Same author

Differentiation of nerve-derived adult pluripotent stem cells into osteoblastic and endothelial cells.

The spine journal : official journal of the North American Spine Society·2016
Same author

Quiescent pluripotent stem cells reside within murine peripheral nerves that can be stimulated to proliferate by recombinant human bone morphogenic protein 2 or by nerve trauma.

The spine journal : official journal of the North American Spine Society·2016

Related Experiment Video

Updated: Mar 30, 2026

Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord
08:39

Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord

Published on: March 18, 2013

32.3K

Gene therapy for spinal fusion using an insect vector.

Michael H Heggeness1

  • 1University of Kansas School of Medicine-Wichita, Robert Dole Veterans Administration Hospital, Wichita, KS, USA.

The Spine Journal : Official Journal of the North American Spine Society
|November 4, 2015
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cells genetically modified to produce bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) significantly improved spinal fusion in rabbits.

More Related Videos

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

4.4K
Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord
08:41

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord

Published on: May 12, 2018

19.1K

Related Experiment Videos

Last Updated: Mar 30, 2026

Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord
08:39

Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord

Published on: March 18, 2013

32.3K
Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

4.4K
Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord
08:41

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord

Published on: May 12, 2018

19.1K

Area of Science:

  • Orthopedics
  • Regenerative Medicine
  • Biotechnology

Background:

  • Spinal fusion is a surgical procedure to permanently connect two or more vertebrae.
  • Achieving successful spinal fusion can be challenging, with non-union rates varying.
  • Bone morphogenetic proteins (BMPs) and growth factors like VEGF are crucial for bone healing and angiogenesis.

Purpose of the Study:

  • To evaluate the efficacy of mesenchymal stem cells (MSCs) engineered to express BMP-2 and VEGF for enhancing posterolateral spine fusion.
  • To assess the potential of a combined gene-delivery approach using MSCs in a preclinical animal model.

Main Methods:

  • Mesenchymal stem cells were genetically modified using a baculovirus vector to co-express BMP-2 and VEGF.
  • These engineered MSCs were implanted in a posterolateral spinal fusion model in rabbits.
  • Radiographic and histological assessments were performed to evaluate the fusion success.

Main Results:

  • Rabbits treated with MSCs engineered for BMP-2 and VEGF showed significantly enhanced posterolateral spine fusion compared to control groups.
  • Histological analysis confirmed robust bone formation and bridging across the fusion site.
  • The combination of BMP-2 and VEGF delivered via MSCs demonstrated synergistic effects on bone regeneration and vascularization.

Conclusions:

  • Baculovirus-engineered mesenchymal stem cells expressing BMP-2 and VEGF are effective in promoting posterolateral spine fusion in a rabbit model.
  • This approach holds promise as a potential therapeutic strategy for improving spinal fusion outcomes in clinical settings.
  • Co-delivery of osteogenic and angiogenic factors via MSCs represents a viable regenerative medicine strategy for spinal fusion.